Alastair Mark Thompson
Baylor College of Medicine · 686 works · 38,337 citations · h-index 84
Top works
- 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
- The repertoire of mutational signatures in human cancer
- Pan-cancer analysis of whole genomes
- Landscape of somatic mutations in 560 breast cancer whole-genome sequences
- Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
- Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
- Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis
- Does wearing two pairs of gloves protect operating theatre staff from skin contamination?
- Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.
- Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
- p53 gene mRNA expression and chromosome 17p allele loss in breast cancer
- Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator
- Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
- Patterns of somatic structural variation in human cancer genomes
- Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)
- p53 allele losses, mutations and expression in breast cancer and their relationship to clinico‐pathological parameters
- Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study
- Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1